The clinicopathologic of pulmonary adenocarcinoma transformation to small cell lung cancer

Transformation to small cell lung cancer (SCLC) is one of the mechanisms of resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). However, it is uncertain how it works and there is no standard treatment after the transformation. In this study, 7 patients with trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Haiyan, Liu, Li, Zhou, Chunhua, Xiong, Yi, Hu, Yijuan, Yang, Nong, Qu, Jingjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708892/
https://www.ncbi.nlm.nih.gov/pubmed/30896637
http://dx.doi.org/10.1097/MD.0000000000014893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708892/
https://www.ncbi.nlm.nih.gov/pubmed/30896637
http://dx.doi.org/10.1097/MD.0000000000014893

Ejemplares similares